Work

FDA Advisory Committee Review of Supplemental Indications and Reasons for Non-Approval, 2008-2022

Year: 2025

Type: article

Source: The Journal of Law Medicine & Ethics

DOI: 10.1017/jme.2025.53

Authors: Audrey D. Zhang, Nikhil Chaudhry, Reshma Ramachandran, Joseph S. Ross, Jason L. Schwartz

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Yale University

Language: English

Topic: Pharmaceutical industry and healthcare

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Arnold Ventures

OpenAlex ID: W4409275572

FWCI: 0.88

Cites: 11

Cited by: 1

Related to: 10